So the plant most likely won't be liquidated, so valued somewhere in the 70-95N range, the buyer saving installation costs, causing the bid to most probably being in the upper part of that range IMO. For ONE location, with customers and contracts in place already, get into the business running.
Then the patents...Are the patents being used in their production process? If so, then they'll likely have to be "purchased" and no one seems to really have a value for those but if used in a successful production process then worth a lot.
Their sales have gone from 2 > 8 > 14M and not even at maximum capacity, 20M in 2018 at that rate of increase? And with capacity increase? 50M possible? And if they could get a hold of costs they would be making money; without 77M write off last year they would have lost less money than 2016. The buyer needs to be one who knows how to control costs and, of course, the first and easiest cost cutting measure is to cut upper management, keeping all of the workers who actually know how to run the plants. Then get the capacity up to increase revenues. Are they bidding for the next 3yrs of sales potential, 45 - 150M?
FYI, I don't know what I'm talking about, looking for valuations, guessing.
$BIOAQ $!+ would be awesome, $1.65 as guidance from the judge, $2 certainly possible.
News 
Market Data 
Discover 
AI
